Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1958

2.
3.

Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).

Sader HS, Jones RN.

Diagn Microbiol Infect Dis. 2009 Oct;65(2):158-62. doi: 10.1016/j.diagmicrobio.2009.06.016.

PMID:
19748426
4.
5.

Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.

Sader HS, Streit JM, Fritsche TR, Jones RN.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):201-4.

PMID:
15541606
6.

Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).

Sader HS, Fritsche TR, Jones RN.

Diagn Microbiol Infect Dis. 2005 Dec;53(4):329-32. Epub 2005 Nov 2.

PMID:
16263233
7.

[Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].

Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, López F, Gómez M; Grupo VIRA.

Enferm Infecc Microbiol Clin. 2010 Jan;28(1):13-6. doi: 10.1016/j.eimc.2008.09.012. Epub 2009 May 5. Spanish.

PMID:
19406529
8.

Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC.

Braz J Infect Dis. 2009 Apr;13(2):90-8.

9.

[Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].

Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R; SENTRY Surveillance Program, Spain (2002-2006).

Enferm Infecc Microbiol Clin. 2008 Oct;26(8):489-94. Spanish.

PMID:
19094861
10.

Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.

Sader HS, Farrell DJ, Jones RN.

Int J Antimicrob Agents. 2010 Jul;36(1):28-32. doi: 10.1016/j.ijantimicag.2010.03.016. Epub 2010 May 4.

PMID:
20444576
11.

In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.

Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.

Int J Antimicrob Agents. 2008 Dec;32(6):525-8. doi: 10.1016/j.ijantimicag.2008.05.020. Epub 2008 Sep 5.

PMID:
18774268
12.
13.
17.

Multicentre assessment of linezolid antimicrobial activity and spectrum in Europe: report from the Zyvox antimicrobial potency study (ZAPS-Europe).

Bolmstrom A, Ballow CH, Qwarnstrom A, Biedenbach DJ, Jones RN.

Clin Microbiol Infect. 2002 Dec;8(12):791-800.

18.

Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.

Picazo JJ, Betriu C, Culebras E, Rodríguez-Avial I, Gómez M, López F; VIRA Study Group.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):448-51. doi: 10.1016/j.diagmicrobio.2009.03.020.

PMID:
19631100
19.

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

Jones RN, Ross JE, Bell JM, Utsuki U, Fumiaki I, Kobayashi I, Turnidge JD.

Diagn Microbiol Infect Dis. 2009 Dec;65(4):404-13. doi: 10.1016/j.diagmicrobio.2009.10.001.

PMID:
19913683
20.
Items per page

Supplemental Content

Write to the Help Desk